睫状视网膜动脉与晚期年龄相关性黄斑变性的关联:年龄相关性黄斑变性治疗比较试验(CATT)的二次分析
该研究为CATT试验的二次分析,纳入350例患者(700眼),评估睫状视网膜动脉(CRA)与5年随访时地图样萎缩(GA)或脉络膜新生血管(CNV)发生率的关联。结果显示,CRA在基线无CNV的对侧眼和有CNV的研究眼中比例相似(19.4% vs 20.9%,P=0.60);CRA与对侧眼5年CNV发生率(45.0% vs 44.8%,P=0.99)、GA发生率(39.6% vs 37.3%,P=0.89)以及研究眼5年GA发生率(38.0% vs 35.6%,P=0.72)均无显著关联。结论认为,在单侧渗出性AMD的CATT参与者中,未发现CRA与CNV或GA发生率之间存在保护性关联。
要点
- 在CATT参与者中,CRA的存在与5年随访时CNV或GA的发生率无显著关联。
- 基线时,有CNV的研究眼与无CNV的对侧眼CRA比例相似(20.9% vs 19.4%,P=0.60)。
- CRA与对侧眼5年CNV发生率(45.0% vs 44.8%,P=0.99)和GA发生率(39.6% vs 37.3%,P=0.89)均无显著关联。
核心结论
- 分析未发现CRA与CATT参与者中单侧渗出性AMD的CNV或GA发生率之间存在保护性关联。
- 这些发现与既往发表结果不同的原因尚不清楚,可能部分归因于检测CRA所用技术不同或CATT参与者的基线晚期病变。
研究设计与样本
- CATT试验的ad hoc二次分析,队列研究,在美国44个临床中心进行。
- 纳入CATT参与者,研究眼有CNV且基线时对侧眼无晚期AMD。
- CRA的存在由2名对临床数据设盲的评分者使用彩色眼底照片、无赤光眼底照片和荧光素血管造影确定。
- 数据收集自2008年2月1日至2015年4月30日,分析自2018年7月1日至2019年4月30日。
主要发现
- 共纳入350例患者(700眼),其中230例(65.7%)为女性,平均(SD)年龄77(7.2)岁。
- 基线无CNV的对侧眼中CRA存在67/345(19.4%),基线有CNV的研究眼中CRA存在73/349(20.9%)(P=0.60)。
- 对侧眼5年CNV发生率:无CRA眼125/278(45.0%),有CRA眼30/67(44.8%)(P=0.99)。
- 对侧眼5年GA发生率:无CRA眼110/278(39.6%),有CRA眼25/67(37.3%)(P=0.89)。
- 研究眼5年GA发生率:无CRA眼105/276(38.0%),有CRA眼26/73(35.6%)(P=0.72)。
局限性
- 这些发现与既往发表结果不同的原因尚不清楚,可能部分归因于检测CRA所用技术不同或CATT参与者的基线晚期病变。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Recent reports suggest that cilioretinal arteries (CRAs) confer protection against developing advanced age-related macular degeneration (AMD). OBJECTIVE: To further characterize the association between the presence of a CRA and incidence of geographic atrophy (GA) or choroidal neovascularization (CNV). DESIGN: This cohort study constituted an ad hoc secondary analysis of data from the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) and was performed at 44 clinical centers in the United States among participants in CATT with CNV in the study eye and without advanced AMD in the fellow eye at baseline. The presence of a CRA was determined by 2 graders, masked to clinical data, using color fundus photographs, red-free fundus photographs, and fluorescein angiography. The proportion with CRAs at baseline between the study eye with CNV and fellow eye without CNV was first compared. The association of a CRA with incidence of CNV or GA at 5 years among fellow eyes and with incidence of GA among study (treated) eyes was then assessed. In addition, the association of CRAs with the Age-Related Eye Disease Study severity scale among the fellow eyes at baseline was assessed. Data were collected from February 1, 2008, through April 30, 2015, and analyzed from July 1, 2018, through April 30, 2019. EXPOSURES: Presence of a CRA. MAIN OUTCOMES AND MEASURES: The association between the presence of a CRA and incidence of CNV or GA at 5 years of follow-up. RESULTS: A total of 350 patients (700 eyes) (230 [65.7% women; mean [SD] age, 77 [7.2] years) were included in the analysis. Cilioretinal arteries were present in 67 of 345 (19.4%) fellow eyes without baseline CNV and 73 of 349 (20.9%) study eyes with baseline CNV (P = .60). Cilioretinal arteries in fellow eyes were not associated with incidence of CNV at 5 years (125 of 278 [45.0%] among eyes without CRAs and 30 of 67 [44.8%] among eyes with CRAs; P = .99) or with incidence of GA at 5 years (110 of 278 [39.6%] among eyes without CRAs and 25 of 67 [37.3%] among eyes with CRAs; P = .89). Cilioretinal arteries in study eyes were not associated with incidence of GA at 5 years (105 of 276 [38.0%] study eyes without CRAs and 26 of 73 [35.6%] study eyes with CRAs; P = .72). CONCLUSIONS AND RELEVANCE: The analysis did not find a protective association between CRAs and incidence of CNV or GA among CATT participants who had unilateral exudative AMD. Why these findings were different from those of previous publications is unclear but may be partially explained by the different techniques used to detect CRAs or by the baseline advanced disease in CATT participants. TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT00593450.
引用
- Bavinger JC, Ying GS, Daniel E, et al. Association Between Cilioretinal Arteries and Advanced Age-Related Macular Degeneration: Secondary Analysis of the Comparison of Age-Related Macular Degeneration Treatment Trials (CATT). JAMA Ophthalmol. 2019. PMID: 31513262. doi:10.1001/jamaophthalmol.2019.3509
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。